Millions of Affordable Care Act customers are waking up to a new reality in 2026, as temporary pandemic-era subsidies vanish ...
Memecoins staged a sharp comeback in early 2026, reversing 2025 losses. Double-digit gains across major tokens like PEPE, ...
A key point in UBS’s analysis is that recent price action was not primarily driven by gold itself. Instead, gold “did little ...
With an estimated half a million workers needed to fill the construction industry’s labor shortages, AI investments this year ...
April 15 is your deadline for filing your 2025 tax return, and it’s also your deadline for funding an IRA for 2025. If you haven’t yet made your contribution, it’s time to get on the stick. For 2025, ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Investing.com -- Zenas BioPharma (NASDAQ:ZBIO) stock fell 50% despite the company announcing results from its Phase 3 INDIGO trial for obexelimab in treating Immunoglobulin G4-Related Disease (IgG4-RD ...